Dr. Daniel Daeyol So, MD

Dr. So practices at Suburban Endocrinology & Diabetes Center in Arlington Heights, Illinois.

Dr. So's NPI, 1023167004, was assigned on January 9, 2007. Dr. So holds Illinois license 036107882.

Dr. So's primary practice is Suburban Endocrinology & Diabetes Center, at 2101 S Arlington Heights Rd Suite 111 Suite 111, Arlington Heights, IL 60005-4197. The practice phone is (847) 228-3200.

Dr. So's primary practice is Suburban Endocrinology & Diabetes Center in Arlington Heights, Illinois. Dr. So is also affiliated with Northwest Community Hospital. The medical group on file is Suburban Endocrinology & Diabetes Center. Dmand AI also links Dr. So to 4 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. So practices, 7 sites in all. Vendor and product names are available with a free account.

Endocrinology, diabetes and metabolism is Dr. So's primary specialty in the NPI Registry, under taxonomy code 207RE0101X. Dr. So is licensed in Illinois.

CMS data shows 2,697 Medicare services from Dr. So across 11 procedure codes in 2024, for 923 Medicare patients. Medicare paid $205,635 for them.

CMS counts 923 Medicare patients who saw Dr. So in 2024. The largest group is 65 to 74, with 391 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. So's median patient age at 69, with 61% women.

In 2024, Dr. So wrote 8,775 Medicare Part D claims for 1,092 patients. 42% of them were for generic drugs. CMS names the drug for 8,300 of them, across 86 drugs with 11 or more claims each, at $3,628,587 in total drug cost. In 2023, CMS named 8,261 claims across 91 drugs.

Dr. So accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. So as offering telehealth.

CMS Open Payments shows 2,450 general payments to Dr. So from 80 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 86% of the total. Sanofi and Genzyme US Companies paid the most, $203,848. It also lists 1 research payment totaling $375 in 2020.